Qualigen Therapeutics
QLGN
QLGN
10 hedge funds and large institutions have $1.47M invested in Qualigen Therapeutics in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
Holders
10
Holders Change
+3
Holders Change %
+42.86%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BC
1
Broadfin Capital
New York
| $879K | 778,000 | – | – |
|
|
BBA
2
Baker Bros. Advisors
New York
| $452K | 400,000 | – | – |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $69K | 60,130 | +99 | +0.2% |
|
|
VKH
4
Virtu KCG Holdings
New York
| $48K | 42,584 | +5,084 | +14% |
|
|
TMC
5
Trellus Management Company
Delray Beach,
Florida
| $20K | 18,000 | – | – |
|
|
BFA
6
BlackRock Fund Advisors
San Francisco,
California
| $1K | 592 | +592 | New |
|
7
UBS Group
Zurich,
Switzerland
| $1K | 805 | +805 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $1K | 814 | +814 | New |
|
9
Citigroup
New York
| – | – | -125 | Closed |
|
10
Morgan Stanley
New York
| $0 | 14 | +1 | +8% |
|
11
Bank of America
Charlotte,
North Carolina
| $0 | 328 | +328 | New |
|